Distinct effects of PPARgamma insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells.
about
Fat and Bone: An Odd CoupleIn vitro models of aortic valve calcification: solidifying a systemMechanotransduction in musculoskeletal tissue regeneration: effects of fluid flow, loading, and cellular-molecular pathways.Calcific aortic valve stenosis: methods, models, and mechanismsAssociation between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma gene and strength athlete status.SIRT1 is a positive regulator of the master osteoblast transcription factor, RUNX2.The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized ratsThe many facets of PPARgamma: novel insights for the skeleton.Cultured human periosteal-derived cells have inducible adipogenic activity and can also differentiate into osteoblasts in a perioxisome proliferator-activated receptor-mediated fashion.Regulation of bone mass by Wnt signaling.Fine-Tuning Reception in the Bone: PPARgamma and Company.Concise review: adipose-derived stromal cells for skeletal regenerative medicinePathophysiological role of enhanced bone marrow adipogenesis in diabetic complications.PPARgamma in human and mouse physiologyPioglitazone attenuates valvular calcification induced by hypercholesterolemia.Upregulation of Adipogenesis and Chondrogenesis in MSC Serum-Free Culture.Peroxisome proliferator-activated receptor-gamma ligands as bone turnover modulators.Effect of Opuntia humifusa supplementation and acute exercise on insulin sensitivity and associations with PPAR-γ and PGC-1α protein expression in skeletal muscle of rats.Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism.The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity.Adipocytes and the regulation of bone remodeling: a balancing act.Lentiviral delivery of PPARγ shRNA alters the balance of osteogenesis and adipogenesis, improving bone microarchitecture.The role of CCAAT/enhancer binding protein (C/EBP)-alpha in osteogenesis of C3H10T1/2 cells induced by BMP-2.Pathophysiology of Aortic Stenosis and Mitral Regurgitation.Regulation of neural crest cell fate by the retinoic acid and Pparg signalling pathways.Adipocytes decrease Runx2 expression in osteoblastic cells: roles of PPARγ and adiponectin.Effects of Osteoglycin (OGN) on treating senile osteoporosis by regulating MSCs.Polymorphisms in the human ALOX12 and ALOX15 genes are associated with peak bone mineral density in Chinese nuclear families.
P2860
Q26865887-20E625F0-E65B-415C-80E4-C79504AA8426Q27022156-DC83C59B-DF81-400C-B712-CE391EB31A53Q30430989-25321EF8-3EAF-4A6D-A756-935FC343964DQ30503246-C3851383-7FA8-4C5A-AE48-EB6126D3E7BBQ31121358-993C2C3E-F76A-4EF4-A62B-F1427D37D155Q33728626-0F2C11B9-BED0-4416-BB4E-70DE8F3EFDA2Q33912894-3A8821EC-BD63-4315-9B09-A01B1EA1790CQ33994438-859D9591-CE5A-42B2-9FD8-2B50142EEEBBQ34102038-74B24849-7B2C-4A11-8F26-8819F9A78722Q34576629-168B282F-F194-49C8-94C3-32A8ED5DEFE4Q35606046-DA5F8310-077D-474F-9335-3E11C98B01C9Q35880841-60D63A10-D561-49C9-8F90-02283802CEACQ35998796-17B7C9E6-0D18-47DF-97D8-96A0CF81AC12Q36063081-DBEE8105-2EAD-44CE-B4BC-1B9077B2B73EQ36612212-B3E72D38-0C32-41A8-B466-A1EADE641601Q36680590-A200248E-FEB8-4379-A2C2-4E8BE6BFF184Q36715753-654C0A2B-0E39-4103-BA5B-ACB866800997Q36820428-45A7955E-E5B3-46EF-91DA-6862D4051093Q36830195-A850CF49-1521-4432-A457-62FC0593A374Q36850959-01E675BD-D709-405E-BB2A-A861B9395EC5Q38062322-EC52ED66-E7F4-45CF-8074-27BCA97FE292Q38150258-1D6BEAFB-D00D-4F0B-B27E-E4E38EA481FCQ38307418-80E7B7F4-09F4-46C8-BA34-F35D8F85FF46Q38357733-1943C98C-9797-4F49-904C-210C0C45E090Q39390979-53138072-C634-400A-BCE8-292B3E8867F8Q40166712-D4067D15-88BF-4680-8CA2-C3661BDB0944Q42825146-A82D85C9-F619-455B-82D3-68EE1EB14818Q46327324-581639BA-CDA6-482A-A69D-9DF8332924C0Q51387976-C4842667-82F1-4B3B-9B35-90AC3D8DBF9B
P2860
Distinct effects of PPARgamma insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Distinct effects of PPARgamma ...... lasts, and osteoclastic cells.
@ast
Distinct effects of PPARgamma ...... lasts, and osteoclastic cells.
@en
type
label
Distinct effects of PPARgamma ...... lasts, and osteoclastic cells.
@ast
Distinct effects of PPARgamma ...... lasts, and osteoclastic cells.
@en
prefLabel
Distinct effects of PPARgamma ...... lasts, and osteoclastic cells.
@ast
Distinct effects of PPARgamma ...... lasts, and osteoclastic cells.
@en
P2093
P2860
P1476
Distinct effects of PPARgamma ...... lasts, and osteoclastic cells.
@en
P2093
Hiroshi Kawaguchi
Kozo Nakamura
Masayuki Yamaguchi
Naoshi Ogata
Naoto Kubota
Shinsuke Ohba
Takashi Kadowaki
Toru Akune
Ung-il Chung
Yasuo Terauchi
P2860
P2888
P304
P356
10.1007/S00774-005-0599-2
P577
2005-01-01T00:00:00Z